img

Global and India Eosinophilic Disease Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Eosinophilic Disease Market Report & Forecast 2024-2034

Eosinophils are the variety of white infection, allergy blood cells and one of the major immune system components helps in combating various and inflammatory diseases. Eosinophils develops and mature in the bone marrow and represent upto 6% of bone marrow. If the threshold of 1500 cells/μl crosses called as eosinophil-driven diseases, which causes severe inflammatory diseases and organ damage.
Market Analysis and InsightsGlobal and India Eosinophilic Disease Market
This report focuses on global and India Eosinophilic Disease market, also covers the segmentation data of other regions in regional level and county level.
The global Eosinophilic Disease revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Eosinophilic Disease revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Eosinophilic Disease include Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company, AstraZeneca, GSK plc, Regeneron Pharmaceuticals Inc, Allakos Inc, Arena Pharmaceuticals Ltd and Revolo Biotherapeutics, etc. The global five biggest players hold a share of % in 2024.
Global Eosinophilic Disease Scope and Market Size
Eosinophilic Disease market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Eosinophilic Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Eosinophilic Disease market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Takeda Pharmaceutical Company Limited
Ellodi Pharmaceuticals
Bristol-Myers Squibb Company
AstraZeneca
GSK plc
Regeneron Pharmaceuticals Inc
Allakos Inc
Arena Pharmaceuticals Ltd
Revolo Biotherapeutics
DBV Technologies
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Segment by Type
Corticosteroids
Monoclonal Antibodies
Anti-cytokine Drug
Cytotoxic Drug

Segment by Application


Eosinophilic Esophagitis
Eosinophilic Granulomatosis with Polyangiitis
Hyper-eosinophilic Syndrome
Nasal Polyposis
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Eosinophilic Disease definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Eosinophilic Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Eosinophilic Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eosinophilic Disease sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Eosinophilic Disease Product Introduction
1.2 Global Eosinophilic Disease Outlook 2018 VS 2024 VS 2034
1.2.1 Global Eosinophilic Disease Sales in US$ Million for the Year 2018-2034
1.2.2 Global Eosinophilic Disease Sales in Volume for the Year 2018-2034
1.3 India Eosinophilic Disease Outlook 2018 VS 2024 VS 2034
1.3.1 India Eosinophilic Disease Sales in US$ Million for the Year 2018-2034
1.3.2 India Eosinophilic Disease Sales in Volume for the Year 2018-2034
1.4 Eosinophilic Disease Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Eosinophilic Disease in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Eosinophilic Disease Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Eosinophilic Disease Market Dynamics
1.5.1 Eosinophilic Disease Industry Trends
1.5.2 Eosinophilic Disease Market Drivers
1.5.3 Eosinophilic Disease Market Challenges
1.5.4 Eosinophilic Disease Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Eosinophilic Disease by Type
2.1 Eosinophilic Disease Market Segment by Type
2.1.1 Corticosteroids
2.1.2 Monoclonal Antibodies
2.1.3 Anti-cytokine Drug
2.1.4 Cytotoxic Drug
2.2 Global Eosinophilic Disease Market Size by Type
2.2.1 Global Eosinophilic Disease Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Eosinophilic Disease Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Eosinophilic Disease Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Eosinophilic Disease Market Size by Type
2.3.1 India Eosinophilic Disease Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Eosinophilic Disease Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Eosinophilic Disease Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Eosinophilic Disease by Application
3.1 Eosinophilic Disease Market Segment by Application
3.1.1 Eosinophilic Esophagitis
3.1.2 Eosinophilic Granulomatosis with Polyangiitis
3.1.3 Hyper-eosinophilic Syndrome
3.1.4 Nasal Polyposis
3.1.5 Other
3.2 Global Eosinophilic Disease Market Size by Application
3.2.1 Global Eosinophilic Disease Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Eosinophilic Disease Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Eosinophilic Disease Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Eosinophilic Disease Market Size by Application
3.3.1 India Eosinophilic Disease Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Eosinophilic Disease Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Eosinophilic Disease Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Eosinophilic Disease Competitor Landscape by Company
4.1 Global Eosinophilic Disease Market Size by Company
4.1.1 Global Key Manufacturers of Eosinophilic Disease, Ranked by Revenue (2024)
4.1.2 Global Eosinophilic Disease Revenue by Manufacturer (2018-2023)
4.1.3 Global Eosinophilic Disease Sales by Manufacturer (2018-2023)
4.1.4 Global Eosinophilic Disease Price by Manufacturer (2018-2023)
4.2 Global Eosinophilic Disease Concentration Ratio (CR)
4.2.1 Eosinophilic Disease Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Eosinophilic Disease in 2024
4.2.3 Global Eosinophilic Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Eosinophilic Disease, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Eosinophilic Disease, Product Offered and Application
4.5 Global Key Manufacturers of Eosinophilic Disease, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Eosinophilic Disease Market Size by Company
4.7.1 Key Players of Eosinophilic Disease in India, Ranked by Revenue (2024)
4.7.2 India Eosinophilic Disease Revenue by Players (2018-2023)
4.7.3 India Eosinophilic Disease Sales by Players (2018-2023)
5 Global Eosinophilic Disease Market Size by Region
5.1 Global Eosinophilic Disease Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Eosinophilic Disease Market Size in Volume by Region (2018-2034)
5.2.1 Global Eosinophilic Disease Sales in Volume by Region: 2018-2023
5.2.2 Global Eosinophilic Disease Sales in Volume Forecast by Region (2024-2034)
5.3 Global Eosinophilic Disease Market Size in Value by Region (2018-2034)
5.3.1 Global Eosinophilic Disease Sales in Value by Region: 2018-2023
5.3.2 Global Eosinophilic Disease Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Eosinophilic Disease Market Size YoY Growth 2018-2034
6.2 Americas Eosinophilic Disease Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Eosinophilic Disease Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Eosinophilic Disease Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Eosinophilic Disease Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Eosinophilic Disease Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Eosinophilic Disease Market Size YoY Growth 2018-2034
7.2 EMEA Eosinophilic Disease Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Eosinophilic Disease Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Eosinophilic Disease Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Eosinophilic Disease Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Eosinophilic Disease Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Eosinophilic Disease Market Size YoY Growth 2018-2034
8.2 China Eosinophilic Disease Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Eosinophilic Disease Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Eosinophilic Disease Market Size YoY Growth 2018-2034
9.2 APAC Eosinophilic Disease Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Eosinophilic Disease Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Eosinophilic Disease Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Eosinophilic Disease Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Eosinophilic Disease Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Takeda Pharmaceutical Company Limited
10.1.1 Takeda Pharmaceutical Company Limited Company Information
10.1.2 Takeda Pharmaceutical Company Limited Description and Business Overview
10.1.3 Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Pharmaceutical Company Limited Eosinophilic Disease Products Offered
10.1.5 Takeda Pharmaceutical Company Limited Recent Development
10.2 Ellodi Pharmaceuticals
10.2.1 Ellodi Pharmaceuticals Company Information
10.2.2 Ellodi Pharmaceuticals Description and Business Overview
10.2.3 Ellodi Pharmaceuticals Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ellodi Pharmaceuticals Eosinophilic Disease Products Offered
10.2.5 Ellodi Pharmaceuticals Recent Development
10.3 Bristol-Myers Squibb Company
10.3.1 Bristol-Myers Squibb Company Company Information
10.3.2 Bristol-Myers Squibb Company Description and Business Overview
10.3.3 Bristol-Myers Squibb Company Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bristol-Myers Squibb Company Eosinophilic Disease Products Offered
10.3.5 Bristol-Myers Squibb Company Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Description and Business Overview
10.4.3 AstraZeneca Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AstraZeneca Eosinophilic Disease Products Offered
10.4.5 AstraZeneca Recent Development
10.5 GSK plc
10.5.1 GSK plc Company Information
10.5.2 GSK plc Description and Business Overview
10.5.3 GSK plc Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GSK plc Eosinophilic Disease Products Offered
10.5.5 GSK plc Recent Development
10.6 Regeneron Pharmaceuticals Inc
10.6.1 Regeneron Pharmaceuticals Inc Company Information
10.6.2 Regeneron Pharmaceuticals Inc Description and Business Overview
10.6.3 Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Regeneron Pharmaceuticals Inc Eosinophilic Disease Products Offered
10.6.5 Regeneron Pharmaceuticals Inc Recent Development
10.7 Allakos Inc
10.7.1 Allakos Inc Company Information
10.7.2 Allakos Inc Description and Business Overview
10.7.3 Allakos Inc Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Allakos Inc Eosinophilic Disease Products Offered
10.7.5 Allakos Inc Recent Development
10.8 Arena Pharmaceuticals Ltd
10.8.1 Arena Pharmaceuticals Ltd Company Information
10.8.2 Arena Pharmaceuticals Ltd Description and Business Overview
10.8.3 Arena Pharmaceuticals Ltd Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Arena Pharmaceuticals Ltd Eosinophilic Disease Products Offered
10.8.5 Arena Pharmaceuticals Ltd Recent Development
10.9 Revolo Biotherapeutics
10.9.1 Revolo Biotherapeutics Company Information
10.9.2 Revolo Biotherapeutics Description and Business Overview
10.9.3 Revolo Biotherapeutics Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Revolo Biotherapeutics Eosinophilic Disease Products Offered
10.9.5 Revolo Biotherapeutics Recent Development
10.10 DBV Technologies
10.10.1 DBV Technologies Company Information
10.10.2 DBV Technologies Description and Business Overview
10.10.3 DBV Technologies Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.10.4 DBV Technologies Eosinophilic Disease Products Offered
10.10.5 DBV Technologies Recent Development
10.11 Cipla Inc
10.11.1 Cipla Inc Company Information
10.11.2 Cipla Inc Description and Business Overview
10.11.3 Cipla Inc Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Cipla Inc Eosinophilic Disease Products Offered
10.11.5 Cipla Inc Recent Development
10.12 Sun Pharmaceutical Industries Ltd
10.12.1 Sun Pharmaceutical Industries Ltd Company Information
10.12.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
10.12.3 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Products Offered
10.12.5 Sun Pharmaceutical Industries Ltd Recent Development
10.13 Sanofi
10.13.1 Sanofi Company Information
10.13.2 Sanofi Description and Business Overview
10.13.3 Sanofi Eosinophilic Disease Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Sanofi Eosinophilic Disease Products Offered
10.13.5 Sanofi Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Eosinophilic Disease Industry Chain Analysis
11.2 Eosinophilic Disease Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Eosinophilic Disease Production Mode & Process
11.4 Eosinophilic Disease Sales and Marketing
11.4.1 Eosinophilic Disease Sales Channels
11.4.2 Eosinophilic Disease Distributors
11.5 Eosinophilic Disease Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Eosinophilic Disease CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Eosinophilic Disease Market Trends
Table 3. Eosinophilic Disease Market Drivers
Table 4. Eosinophilic Disease Market Challenges
Table 5. Eosinophilic Disease Market Restraints
Table 6. Global Eosinophilic Disease Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Eosinophilic Disease Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Eosinophilic Disease Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Eosinophilic Disease Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Eosinophilic Disease, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Eosinophilic Disease Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Eosinophilic Disease Revenue Share by Manufacturer, 2018-2023
Table 13. Global Eosinophilic Disease Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Eosinophilic Disease Sales Share by Manufacturer, 2018-2023
Table 15. Global Eosinophilic Disease Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Eosinophilic Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Eosinophilic Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Disease as of 2024)
Table 18. Global Key Manufacturers of Eosinophilic Disease, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Eosinophilic Disease, Product Offered and Application
Table 20. Global Key Manufacturers of Eosinophilic Disease, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Eosinophilic Disease in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Eosinophilic Disease Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Eosinophilic Disease Revenue Share by Players, (2018-2023)
Table 25. India Eosinophilic Disease Sales by Players, (K Units), (2018-2023)
Table 26. India Eosinophilic Disease Sales Share by Players, (2018-2023)
Table 27. Global Eosinophilic Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Eosinophilic Disease Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Eosinophilic Disease Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Eosinophilic Disease Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Eosinophilic Disease Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Eosinophilic Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Eosinophilic Disease Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Eosinophilic Disease Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Eosinophilic Disease Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Eosinophilic Disease Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Eosinophilic Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Eosinophilic Disease Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Eosinophilic Disease Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Eosinophilic Disease Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Eosinophilic Disease Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Eosinophilic Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Eosinophilic Disease Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Eosinophilic Disease Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Eosinophilic Disease Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Eosinophilic Disease Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Takeda Pharmaceutical Company Limited Company Information
Table 48. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 49. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Takeda Pharmaceutical Company Limited Eosinophilic Disease Product
Table 51. Takeda Pharmaceutical Company Limited Recent Development
Table 52. Ellodi Pharmaceuticals Company Information
Table 53. Ellodi Pharmaceuticals Description and Business Overview
Table 54. Ellodi Pharmaceuticals Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Ellodi Pharmaceuticals Eosinophilic Disease Product
Table 56. Ellodi Pharmaceuticals Recent Development
Table 57. Bristol-Myers Squibb Company Company Information
Table 58. Bristol-Myers Squibb Company Description and Business Overview
Table 59. Bristol-Myers Squibb Company Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Bristol-Myers Squibb Company Eosinophilic Disease Product
Table 61. Bristol-Myers Squibb Company Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Description and Business Overview
Table 64. AstraZeneca Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. AstraZeneca Eosinophilic Disease Product
Table 66. AstraZeneca Recent Development
Table 67. GSK plc Company Information
Table 68. GSK plc Description and Business Overview
Table 69. GSK plc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. GSK plc Eosinophilic Disease Product
Table 71. GSK plc Recent Development
Table 72. Regeneron Pharmaceuticals Inc Company Information
Table 73. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 74. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Regeneron Pharmaceuticals Inc Eosinophilic Disease Product
Table 76. Regeneron Pharmaceuticals Inc Recent Development
Table 77. Allakos Inc Company Information
Table 78. Allakos Inc Description and Business Overview
Table 79. Allakos Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Allakos Inc Eosinophilic Disease Product
Table 81. Allakos Inc Recent Development
Table 82. Arena Pharmaceuticals Ltd Company Information
Table 83. Arena Pharmaceuticals Ltd Description and Business Overview
Table 84. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Arena Pharmaceuticals Ltd Eosinophilic Disease Product
Table 86. Arena Pharmaceuticals Ltd Recent Development
Table 87. Revolo Biotherapeutics Company Information
Table 88. Revolo Biotherapeutics Description and Business Overview
Table 89. Revolo Biotherapeutics Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Revolo Biotherapeutics Eosinophilic Disease Product
Table 91. Revolo Biotherapeutics Recent Development
Table 92. DBV Technologies Company Information
Table 93. DBV Technologies Description and Business Overview
Table 94. DBV Technologies Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. DBV Technologies Eosinophilic Disease Product
Table 96. DBV Technologies Recent Development
Table 97. Cipla Inc Company Information
Table 98. Cipla Inc Description and Business Overview
Table 99. Cipla Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Cipla Inc Eosinophilic Disease Product
Table 101. Cipla Inc Recent Development
Table 102. Sun Pharmaceutical Industries Ltd Company Information
Table 103. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 104. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product
Table 106. Sun Pharmaceutical Industries Ltd Recent Development
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Business Overview
Table 109. Sanofi Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Sanofi Eosinophilic Disease Product
Table 111. Sanofi Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Eosinophilic Disease Customers List
Table 115. Eosinophilic Disease Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Disease Product Picture
Figure 2. Global Eosinophilic Disease Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Eosinophilic Disease Market Size 2018-2034 (US$ Million)
Figure 4. Global Eosinophilic Disease Sales 2018-2034 (K Units)
Figure 5. India Eosinophilic Disease Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Eosinophilic Disease Market Size 2018-2034 (US$ Million)
Figure 7. India Eosinophilic Disease Sales 2018-2034 (K Units)
Figure 8. India Eosinophilic Disease Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Eosinophilic Disease Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Eosinophilic Disease Report Years Considered
Figure 11. Product Picture of Corticosteroids
Figure 12. Product Picture of Monoclonal Antibodies
Figure 13. Product Picture of Anti-cytokine Drug
Figure 14. Product Picture of Cytotoxic Drug
Figure 15. Global Eosinophilic Disease Market Share by Type in 2024 & 2034
Figure 16. Global Eosinophilic Disease Sales in Value by Type (2018-2034) & (US$ Million)
Figure 17. Global Eosinophilic Disease Sales Market Share in Value by Type (2018-2034)
Figure 18. Global Eosinophilic Disease Sales by Type (2018-2034) & (K Units)
Figure 19. Global Eosinophilic Disease Sales Market Share in Volume by Type (2018-2034)
Figure 20. Global Eosinophilic Disease Price by Type (2018-2034) & (US$/Unit)
Figure 21. India Eosinophilic Disease Market Share by Type in 2024 & 2034
Figure 22. India Eosinophilic Disease Sales in Value by Type (2018-2034) & (US$ Million)
Figure 23. India Eosinophilic Disease Sales Market Share in Value by Type (2018-2034)
Figure 24. India Eosinophilic Disease Sales by Type (2018-2034) & (K Units)
Figure 25. India Eosinophilic Disease Sales Market Share in Volume by Type (2018-2034)
Figure 26. India Eosinophilic Disease Price by Type (2018-2034) & (US$/Unit)
Figure 27. Product Picture of Eosinophilic Esophagitis
Figure 28. Product Picture of Eosinophilic Granulomatosis with Polyangiitis
Figure 29. Product Picture of Hyper-eosinophilic Syndrome
Figure 30. Product Picture of Nasal Polyposis
Figure 31. Product Picture of Other
Figure 32. Global Eosinophilic Disease Market Share by Application in 2024 & 2034
Figure 33. Global Eosinophilic Disease Sales in Value by Application (2018-2034) & (US$ Million)
Figure 34. Global Eosinophilic Disease Sales Market Share in Value by Application (2018-2034)
Figure 35. Global Eosinophilic Disease Sales by Application (2018-2034) & (K Units)
Figure 36. Global Eosinophilic Disease Sales Market Share in Volume by Application (2018-2034)
Figure 37. Global Eosinophilic Disease Price by Application (2018-2034) & (US$/Unit)
Figure 38. India Eosinophilic Disease Market Share by Application in 2024 & 2034
Figure 39. India Eosinophilic Disease Sales in Value by Application (2018-2034) & (US$ Million)
Figure 40. India Eosinophilic Disease Sales Market Share in Value by Application (2018-2034)
Figure 41. India Eosinophilic Disease Sales by Application (2018-2034) & (K Units)
Figure 42. India Eosinophilic Disease Sales Market Share in Volume by Application (2018-2034)
Figure 43. India Eosinophilic Disease Price by Application (2018-2034) & (US$/Unit)
Figure 44. Americas Eosinophilic Disease Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 45. Americas Eosinophilic Disease Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 46. Americas Eosinophilic Disease Sales by Type (2018-2034) & (K Units)
Figure 47. Americas Eosinophilic Disease Sales Market Share in Volume by Type (2018-2034)
Figure 48. Americas Eosinophilic Disease Sales by Application (2018-2034) & (K Units)
Figure 49. Americas Eosinophilic Disease Sales Market Share in Volume by Application (2018-2034)
Figure 50. United States Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Canada Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Mexico Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 54. EMEA Eosinophilic Disease Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 55. EMEA Eosinophilic Disease Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 56. EMEA Eosinophilic Disease Sales by Type (2018-2034) & (K Units)
Figure 57. EMEA Eosinophilic Disease Sales Market Share in Volume by Type (2018-2034)
Figure 58. EMEA Eosinophilic Disease Sales by Application (2018-2034) & (K Units)
Figure 59. EMEA Eosinophilic Disease Sales Market Share in Volume by Application (2018-2034)
Figure 60. Europe Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Middle East Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. Africa Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 63. China Eosinophilic Disease Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 64. China Eosinophilic Disease Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 65. China Eosinophilic Disease Sales by Type (2018-2034) & (K Units)
Figure 66. China Eosinophilic Disease Sales Market Share in Volume by Type (2018-2034)
Figure 67. China Eosinophilic Disease Sales by Application (2018-2034) & (K Units)
Figure 68. China Eosinophilic Disease Sales Market Share in Volume by Application (2018-2034)
Figure 69. APAC Eosinophilic Disease Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 70. APAC Eosinophilic Disease Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 71. APAC Eosinophilic Disease Sales by Type (2018-2034) & (K Units)
Figure 72. APAC Eosinophilic Disease Sales Market Share in Volume by Type (2018-2034)
Figure 73. APAC Eosinophilic Disease Sales by Application (2018-2034) & (K Units)
Figure 74. APAC Eosinophilic Disease Sales Market Share in Volume by Application (2018-2034)
Figure 75. Japan Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. South Korea Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. China Taiwan Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. India Eosinophilic Disease Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 80. Eosinophilic Disease Value Chain
Figure 81. Eosinophilic Disease Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed